SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-091022
Filing Date
2023-08-14
Accepted
2023-08-14 09:05:08
Documents
14
Period of Report
2023-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323630d1_8k.htm   iXBRL 8-K 24217
2 EXHIBIT 99.1 tm2323630d1_ex99-1.htm EX-99.1 61273
6 GRAPHIC tm2323630d1_ex99-1img001.jpg GRAPHIC 3089
  Complete submission text file 0001104659-23-091022.txt   275188

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jagx-20230814.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20230814_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20230814_pre.xml EX-101.PRE 22379
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2323630d1_8k_htm.xml XML 3314
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 231166669
SIC: 2834 Pharmaceutical Preparations